Blavatnik Len's Form 4 filing
Verona Pharma plc (VRNA) · filed Aug 17, 2022
- Accession no.
- 0001209191-22-046214
- Filed
- Aug 17, 2022, 4:03 PM ET
- Trade date
- Aug 15, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $6.30M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blavatnik LenCIK 0001326628 | 10% Owner |
| Access Industries Holdings LLCCIK 0001391297 | 10% Owner |
| Access Industries Management, LLCCIK 0001508226 | 10% Owner |
| AI Biotechnology LLCCIK 0001942670 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2022 | Ordinary Shares | PPurchaseAcquired | +4,800,000 | $1.31F2 | +$6,300,000 | 55,911,648 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported represents the purchase price of the ADSs divided by eight.
Referenced by the price of 1 transaction in Table I.